Testing effectiveness (Phase 2)Study completedNCT01350128
What this trial is testing
PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Who this might be right for
Chronic Obstructive Pulmonary Disease
Pearl Therapeutics, Inc. 103